xh-s004
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 26, 2024 (NCT06236841)
Timeline
Indications
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07035652 | Phase 1 | Jul 15, 2025 | Infinity Pharmaceuticals, Inc. |
| NCT06981091 | Phase 2 | May 16, 2025 | Infinity Pharmaceuticals, Inc. |
| NCT06236841 | Phase 1 | Jan 26, 2024 | Infinity Pharmaceuticals, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1